Updated on 11 September 2026
Expertise in HORIZON-HLTH-2027-01-CARE-02
Medical Oncologist/Associate professor/ Lead of Tumor Molecular Board at Lithuanian university of health sciences
Kaunas, Lithuania
About
LSMU Kauno Klinikos has extensive experience in clinical management of complex patients receiving multiple treatments, particularly in oncology and chronic disease care. Dr. Kupčinskaitė's expertise in molecular diagnostics and personalized medicine supports the development of individualized treatment strategies that improve efficacy and safety. The institution can contribute clinical evidence, patient cohorts, biomarker-based stratification approaches, and real-world data relevant to treatment optimization. Through multidisciplinary collaboration involving clinicians, pharmacologists, and researchers, LSMU KK can support studies aimed at predicting treatment responses and minimizing adverse drug reactions. The team is particularly interested in innovative approaches combining clinical, molecular, and digital data to improve medication safety and personalized healthcare.
Topic
- Healthcare innovations: HORIZON-HLTH-2027-01-CARE-02 Personalised approaches to reduce risks from Adverse Drug Reactions due to administration of multiple medications
Type
- Partner seeks Consortium/Coordinator
Similar opportunities
Project cooperation
Expertise for HORIZON-MISS-2027-02-CANCER-01
- Partner seeks Consortium/Coordinator
- Healthcare innovations: HORIZON-MISS-2027-02-CANCER-01 Leveraging functional genomics to reveal novel targets for cancer treatment
Rita Kupcinskaite
Medical Oncologist/Associate professor/ Lead of Tumor Molecular Board at Lithuanian university of health sciences
Kaunas, Lithuania
Project cooperation
Expertise in HORIZON-MISS-2027-02-CANCER-04
- Partner seeks Consortium/Coordinator
- Healthcare innovations: HORIZON-MISS-2027-02-CANCER-04 Improving equitable health outcomes and added value for and with cancer patients through health-economics research, health systems research and outcomes research
Rita Kupcinskaite
Medical Oncologist/Associate professor/ Lead of Tumor Molecular Board at Lithuanian university of health sciences
Kaunas, Lithuania
Project cooperation
Expertise for HORIZON-HLTH-2027-01-CARE-02
- Partner seeks Consortium/Coordinator
- Healthcare innovations: HORIZON-HLTH-2027-01-CARE-02 Personalised approaches to reduce risks from Adverse Drug Reactions due to administration of multiple medications
Erika Korobeinikova
Assoc. Prof. at Lithuanian university of health sciences
Kaunas, Lithuania